A Study Assessing the Tolerable Upper Intake Level and Safety of Sugars From Fiber

Exclusion Criteria

• •Females who are pregnant, lactating or wish to become pregnant during the study;
• •Participant has self-reported low-energy diet or other extreme dietary habits;
• •Have experienced recurrent loose stool within the past 4 weeks;
• •Recent gastroenteritis or food borne illness such as confirmed food poisoning within the past 4 weeks;
• •Have taken a medication or dietary supplement that may influence GI activity within the 2-weeks prior to screening;
• •Have a history of abdominal surgery (excluding appendectomy);
• •Have taken anaesthesia within the past 4 weeks;
• •Have a known or suspected food allergy or intolerance to any of the investigational product ingredients;
• •Have taken antibiotics within the past 12-weeks;
• •Have a recent history of drug and/or alcohol abuse at the time of enrolment;
• •Are a smoker (defined as \>5 cigarettes/week);
• •Have made any major dietary change in the past 3 months;
• •Have planned major changes in lifestyle (i.e. diet, dieting, exercise level, travelling) during the duration of the study;
• •Have an active gastrointestinal disorder or previous gastrointestinal surgery;
• •Have irritable bowel syndrome, diagnosed or undiagnosed and treated with chronic medications;
• •Have a gastrointestinal disease i.e., chronic diarrhoea, Crohn's disease, ulcerative colitis, diverticulosis, stomach or duodenal ulcers, or with a history of such diseases;
• •Have a metabolic or endocrine disorder such as diabetes, thyroidism, or other metabolic disorder;
• •Have a severe chronic disease i.e. cancer, renal failure, hepatitis, HIV, cirrhosis etc., or with a history of such diseases;
• •Are severely immunocompromised (HIV positive, transplant patient, on antirejection medications, on a systemic steroid for \>30 days, or chemotherapy or radiotherapy within the last year);
• •Have a personal history of anorexia nervosa, bulimia, or significant eating disorders;
• •Experiences alarm features such as unintentional weight loss, rectal bleeding, recent change in bowel habit (\<3 months) or abdominal pain;
• •Participants who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial;
• •Participant is currently receiving treatment involving experimental drugs. If the participant has been in a recent experimental trial, these must have been completed not less than 30 days prior to this study.